Cargando…

Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning

MOTIVATION: In recent years, cyclic peptide drugs have been receiving increasing attention because they can target proteins that are difficult to be tackled by conventional small-molecule drugs or antibody drugs. Plasma protein binding rate ([Formula: see text]) is a significant pharmacokinetic prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianan, Yanagisawa, Keisuke, Yoshikawa, Yasushi, Ohue, Masahito, Akiyama, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796384/
https://www.ncbi.nlm.nih.gov/pubmed/34849593
http://dx.doi.org/10.1093/bioinformatics/btab726
_version_ 1784641298972540928
author Li, Jianan
Yanagisawa, Keisuke
Yoshikawa, Yasushi
Ohue, Masahito
Akiyama, Yutaka
author_facet Li, Jianan
Yanagisawa, Keisuke
Yoshikawa, Yasushi
Ohue, Masahito
Akiyama, Yutaka
author_sort Li, Jianan
collection PubMed
description MOTIVATION: In recent years, cyclic peptide drugs have been receiving increasing attention because they can target proteins that are difficult to be tackled by conventional small-molecule drugs or antibody drugs. Plasma protein binding rate ([Formula: see text]) is a significant pharmacokinetic property of a compound in drug discovery and design. However, due to structural differences, previous computational prediction methods developed for small-molecule compounds cannot be successfully applied to cyclic peptides, and methods for predicting the PPB rate of cyclic peptides with high accuracy are not yet available. RESULTS: Cyclic peptides are larger than small molecules, and their local structures have a considerable impact on PPB; thus, molecular descriptors expressing residue-level local features of cyclic peptides, instead of those expressing the entire molecule, as well as the circularity of the cyclic peptides should be considered. Therefore, we developed a prediction method named CycPeptPPB using deep learning that considers both factors. First, the macrocycle ring of cyclic peptides was decomposed residue by residue. The residue-based descriptors were arranged according to the sequence information of the cyclic peptide. Furthermore, the circular data augmentation method was used, and the circular convolution method CyclicConv was devised to express the cyclic structure. CycPeptPPB exhibited excellent performance, with mean absolute error (MAE) of 4.79% and correlation coefficient (R) of 0.92 for the public drug dataset, compared to the prediction performance of the existing PPB rate prediction software ([Formula: see text]). AVAILABILITY AND IMPLEMENTATION: The data underlying this article are available in the online supplementary material. The source code of CycPeptPPB is available at https://github.com/akiyamalab/cycpeptppb. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-8796384
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-87963842022-01-31 Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning Li, Jianan Yanagisawa, Keisuke Yoshikawa, Yasushi Ohue, Masahito Akiyama, Yutaka Bioinformatics Original Papers MOTIVATION: In recent years, cyclic peptide drugs have been receiving increasing attention because they can target proteins that are difficult to be tackled by conventional small-molecule drugs or antibody drugs. Plasma protein binding rate ([Formula: see text]) is a significant pharmacokinetic property of a compound in drug discovery and design. However, due to structural differences, previous computational prediction methods developed for small-molecule compounds cannot be successfully applied to cyclic peptides, and methods for predicting the PPB rate of cyclic peptides with high accuracy are not yet available. RESULTS: Cyclic peptides are larger than small molecules, and their local structures have a considerable impact on PPB; thus, molecular descriptors expressing residue-level local features of cyclic peptides, instead of those expressing the entire molecule, as well as the circularity of the cyclic peptides should be considered. Therefore, we developed a prediction method named CycPeptPPB using deep learning that considers both factors. First, the macrocycle ring of cyclic peptides was decomposed residue by residue. The residue-based descriptors were arranged according to the sequence information of the cyclic peptide. Furthermore, the circular data augmentation method was used, and the circular convolution method CyclicConv was devised to express the cyclic structure. CycPeptPPB exhibited excellent performance, with mean absolute error (MAE) of 4.79% and correlation coefficient (R) of 0.92 for the public drug dataset, compared to the prediction performance of the existing PPB rate prediction software ([Formula: see text]). AVAILABILITY AND IMPLEMENTATION: The data underlying this article are available in the online supplementary material. The source code of CycPeptPPB is available at https://github.com/akiyamalab/cycpeptppb. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2021-11-22 /pmc/articles/PMC8796384/ /pubmed/34849593 http://dx.doi.org/10.1093/bioinformatics/btab726 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Li, Jianan
Yanagisawa, Keisuke
Yoshikawa, Yasushi
Ohue, Masahito
Akiyama, Yutaka
Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title_full Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title_fullStr Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title_full_unstemmed Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title_short Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
title_sort plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796384/
https://www.ncbi.nlm.nih.gov/pubmed/34849593
http://dx.doi.org/10.1093/bioinformatics/btab726
work_keys_str_mv AT lijianan plasmaproteinbindingpredictionfocusingonresiduelevelfeaturesandcircularityofcyclicpeptidesbydeeplearning
AT yanagisawakeisuke plasmaproteinbindingpredictionfocusingonresiduelevelfeaturesandcircularityofcyclicpeptidesbydeeplearning
AT yoshikawayasushi plasmaproteinbindingpredictionfocusingonresiduelevelfeaturesandcircularityofcyclicpeptidesbydeeplearning
AT ohuemasahito plasmaproteinbindingpredictionfocusingonresiduelevelfeaturesandcircularityofcyclicpeptidesbydeeplearning
AT akiyamayutaka plasmaproteinbindingpredictionfocusingonresiduelevelfeaturesandcircularityofcyclicpeptidesbydeeplearning